Transcode Therapeutics, Inc. (RNAZ)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.41
- As of
Kresmion compiles this page from RNAZ's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Transcode Therapeutics, Inc. (RNAZ): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-16.
See the full RNAZ dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for RNAZ on one page. Preview it with sample data, then open it live with a free account.
Preview the RNAZ dossierActive events for RNAZ
- mediumEarnings above estimates
Q1-2024: Beat consensus by 24.4% - EPS $-498.96 vs $-659.736 estimate
FREE, NO ACCOUNT
Every event on RNAZ, as it fires
New filings, 13F moves and cross asset events on RNAZ land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, RNAZ
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
RNAZ's 10-Q filed Nov 16, 2026 states:
…Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming…
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on RNAZ
RNAZ mentioned in Kresmion daily briefs
Cite this data
Kresmion counts the managers it follows that reported a non-option position in RNAZ on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on RNAZ in the last 180 days.
Upstream: SEC EDGAR filings for RNAZ
Kresmion, "Transcode Therapeutics, Inc. (RNAZ) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/RNAZ. Upstream data: SEC EDGAR filings for RNAZ.
Link to this data (HTML):
<a href="https://kresmion.com/research/RNAZ">Transcode Therapeutics, Inc. (RNAZ) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow RNAZ on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to RNAZ for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.